Skip to main content
. 2019 Feb 1;11(2):305. doi: 10.3390/nu11020305

Table 1.

Baseline demographic and clinical characteristics of study participants (n = 100).

Characteristics Treatment Groups p-Value
Placebo
(n = 50)
DW2009 Group
(n = 50)
Demographic characteristics
  Age, mean, (SD) 69.2 (7.00) 68.0 (5.12) 0.35
  Women, No. (%) 36 (72.0) 30 (60.0) 0.21
  Education, No. (%)
   0–11 years 25 (50.0) 30 (60.0) 0.43
   12 years 17 (34.0) 16 (32.0)
   13 years or more 8 (16.0) 4 (8.00)
  Marital status, No. (%)
   Married 50 (100) 49 (98.0) 1.00
   Divorced, widowed, or separated 0 (0.00) 1 (2.00)
Clinical characteristics
  Auditory continuous performance test 1
   Reaction time 0.77 (0.08) 0.79 (0.08) 0.13
   Correct response 127 (9.41) 121 (20.2) 0.04
   Incorrect response 6.29 (6.15) 9.22 (8.12) 0.05
   Omission error 7.71 (9.40) 14.2 (20.2) 0.04
  Digit span test
   List memory score 7.44 (3.35) 7.34 (3.66) 0.89
   Tracking score 5.26 (1.23) 5.34 (1.45) 0.77
  Verbal learning test
   Immediate recall 9.04 (2.22) 8.30 (2.35) 0.11
   Delayed recall 7.30 (2.62) 6.84 (2.91) 0.41
   Recognition 11.3 (2.34) 10.6 (3.21) 0.19

1 Data from one subject of the placebo-administered group was not available. p-values were calculated using the independent t-test for continuous variables and chi-squared test or Fisher’s exact test for categorical variables. SD: standard deviation; No.: number.